Robert Zaczek

5.8k total citations
91 papers, 3.8k citations indexed

About

Robert Zaczek is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert Zaczek has authored 91 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cellular and Molecular Neuroscience, 39 papers in Molecular Biology and 23 papers in Pharmacology. Recurrent topics in Robert Zaczek's work include Neuroscience and Neuropharmacology Research (50 papers), Cholinesterase and Neurodegenerative Diseases (20 papers) and Stress Responses and Cortisol (18 papers). Robert Zaczek is often cited by papers focused on Neuroscience and Neuropharmacology Research (50 papers), Cholinesterase and Neurodegenerative Diseases (20 papers) and Stress Responses and Cortisol (18 papers). Robert Zaczek collaborates with scholars based in United States, Germany and Poland. Robert Zaczek's co-authors include Joseph T. Coyle, Kerry J. Koller, John W. Ferkany, Paul J. Gilligan, Steven Culp, David W. Robertson, E B De Souza, Robert Schwarcz, J. T. Coyle and Charles F. Albright and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert Zaczek

91 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Zaczek United States	35	2.3k	1.7k	447	407	374	91	3.8k
David W. Schulz United States	28	1.5k 0.6×	1.5k 0.8×	585 1.3×	231 0.6×	426 1.1×	37	2.9k
Richard Bergeron Canada	32	2.2k 1.0×	2.0k 1.2×	463 1.0×	429 1.1×	332 0.9×	65	4.3k
Xavier Langlois Belgium	38	2.3k 1.0×	2.1k 1.2×	292 0.7×	397 1.0×	510 1.4×	104	4.2k
Markus Kessler United States	40	2.7k 1.2×	2.6k 1.5×	247 0.6×	806 2.0×	492 1.3×	79	5.4k
David B. Bylund United States	32	2.4k 1.0×	2.3k 1.3×	366 0.8×	200 0.5×	670 1.8×	89	4.1k
I J Kopin United States	34	2.1k 0.9×	1.1k 0.6×	368 0.8×	383 0.9×	667 1.8×	70	4.2k
Michael F. Mazurek Canada	30	2.0k 0.8×	1.3k 0.8×	199 0.4×	257 0.6×	546 1.5×	56	3.4k
Thomas P. Blackburn United States	30	2.2k 0.9×	1.6k 0.9×	239 0.5×	440 1.1×	320 0.9×	70	3.6k
Naoya Kawashima Japan	20	2.2k 0.9×	1.3k 0.7×	214 0.5×	244 0.6×	531 1.4×	37	3.0k
Matthew P. Galloway United States	35	1.9k 0.8×	1.2k 0.7×	399 0.9×	520 1.3×	362 1.0×	86	3.5k

Countries citing papers authored by Robert Zaczek

Since Specialization

Citations

This map shows the geographic impact of Robert Zaczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zaczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zaczek more than expected).

Fields of papers citing papers by Robert Zaczek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Zaczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zaczek. The network helps show where Robert Zaczek may publish in the future.

Co-authorship network of co-authors of Robert Zaczek

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Zaczek. A scholar is included among the top collaborators of Robert Zaczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Zaczek. Robert Zaczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Myers, Scott J., Lawrence J. Wilson, Yesim A. Tahirovic, et al.. (2021). A Glutamate N-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B–Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical Use. Journal of Pharmacology and Experimental Therapeutics. 379(1). 41–52. 10 indexed citations

Li, Yu-Wen, Matthew A. Seager, Karen Heman, et al.. (2015). Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy. Neuropharmacology. 102. 121–135. 15 indexed citations

Lodge, Nicholas J., Frederick T. Chin, Douglas D. Dischino, et al.. (2014). Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors. Nuclear Medicine and Biology. 41(6). 524–535. 14 indexed citations

Dzierba, Carolyn D., Thais M. Sielecki, Argyrios G. Arvanitis, et al.. (2012). Synthesis and structure–activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(15). 4986–4989. 5 indexed citations

Yang, Michael G., J. SCOTT WELLS, Brian M. Cochran, et al.. (2007). Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(14). 3910–3915. 12 indexed citations

Goldstein, Margi E., Yang Cao, Jeremy H. Toyn, et al.. (2007). Ex Vivo Occupancy of γ-Secretase Inhibitors Correlates with Brain β-Amyloid Peptide Reduction in Tg2576 Mice. Journal of Pharmacology and Experimental Therapeutics. 323(1). 102–108. 8 indexed citations

Iben, Lawrence G., Richard E. Olson, Sukhanya Jayachandra, et al.. (2007). Signal Peptide Peptidase and γ-Secretase Share Equivalent Inhibitor Binding Pharmacology. Journal of Biological Chemistry. 282(51). 36829–36836. 19 indexed citations

Dzierba, Carolyn D., Amy Takvorian, Maria Rafalski, et al.. (2004). Synthesis, Structure−Activity Relationships, and in Vivo Properties of 3,4-Dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as Corticotropin-Releasing Factor-1 Receptor Antagonists. Journal of Medicinal Chemistry. 47(23). 5783–5790. 11 indexed citations

Arvanitis, Argyrios G., Richard G. Wilde, Gary A. Cain, et al.. (2003). Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands. Bioorganic & Medicinal Chemistry Letters. 13(1). 125–128. 11 indexed citations

10.

Arvanitis, Argyrios G., Richard G. Wilde, Lawrence W. Fitzgerald, et al.. (2003). Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands. Bioorganic & Medicinal Chemistry Letters. 13(1). 129–131. 7 indexed citations

11.

Szewczyk, Grzegorz, Dariusz Szukiewicz, Robert Zaczek, & D. Maślińska. (2000). Mast cells in the mouse mammary gland--correlation with the development of lactiferous structures.. PubMed. 48(1-2). 13–7. 7 indexed citations

12.

Beck, James P., et al.. (1999). Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(7). 967–972. 26 indexed citations

13.

Beck, James P., et al.. (1999). Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(8). 1185–1188. 24 indexed citations

14.

Lehmann, John, et al.. (1992). Regional Distribution to Recovery of 5‐HT Levels after Administration of “Atrophins” MDMA and D, L‐Fenfluramine Stereospecificity and Comparison with 5,7‐Dihydroxytryptamine. Annals of the New York Academy of Sciences. 648(1). 291–295. 4 indexed citations

15.

Zaczek, Robert, Steven Culp, Harry Goldberg, David J. McCann, & E B De Souza. (1991). Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 820–829. 34 indexed citations

16.

Zaczek, Robert, Giuseppe Battaglia, Steven Culp, et al.. (1990). Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 104–112. 101 indexed citations

17.

Zaczek, Robert, et al.. (1984). Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.. PubMed. 5(6). 617–24. 17 indexed citations

18.

Ferkany, John W., et al.. (1984). Glutamate-containing dipeptides enhance specific binding at glutamate receptors and inhibit specific binding at kainate receptors in rat brain. Neuroscience Letters. 44(3). 281–286. 10 indexed citations

19.

Zaczek, Robert, et al.. (1983). Failure of folic acid derivatives to mimic the actions of kainic acid in brain in vitro or in vivo.. PubMed. 4(5). 573–9. 11 indexed citations

20.

Zaczek, Robert, et al.. (1981). Neuronal receptor sites for kainic acid: correlations with neurotoxicity.. PubMed. 27. 337–46. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact